

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08833300 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08833300 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.08013454 |
| 4 | protein carboxylation (GO:0018214) | 4.00379276 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.00379276 |
| 6 | apoptotic cell clearance (GO:0043277) | 3.84860471 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.81277891 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.77315633 |
| 9 | negative regulation of cell killing (GO:0031342) | 3.77315633 |
| 10 | complement activation, alternative pathway (GO:0006957) | 3.75102200 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.75052403 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.75052403 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.75052403 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.75052403 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.75052403 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.75052403 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68547841 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57454509 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.57049538 |
| 20 | low-density lipoprotein particle clearance (GO:0034383) | 3.46026213 |
| 21 | plasma lipoprotein particle clearance (GO:0034381) | 3.35001721 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.34338219 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 3.34338219 |
| 24 | regulation of protein activation cascade (GO:2000257) | 3.32286050 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 3.31505334 |
| 26 | regulation of complement activation (GO:0030449) | 3.26341743 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 3.23746045 |
| 28 | L-phenylalanine metabolic process (GO:0006558) | 3.23655825 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.23655825 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.23551927 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 3.23551927 |
| 32 | regulation of cholesterol storage (GO:0010885) | 3.18070104 |
| 33 | regulation of cholesterol homeostasis (GO:2000188) | 3.17299159 |
| 34 | reverse cholesterol transport (GO:0043691) | 3.16509807 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 3.16165016 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.08953800 |
| 37 | phospholipid efflux (GO:0033700) | 3.07152462 |
| 38 | urea cycle (GO:0000050) | 3.06096108 |
| 39 | urea metabolic process (GO:0019627) | 3.06096108 |
| 40 | valine metabolic process (GO:0006573) | 3.04757859 |
| 41 | keratan sulfate catabolic process (GO:0042340) | 3.04155431 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99283632 |
| 43 | virion attachment to host cell (GO:0019062) | 2.94932514 |
| 44 | adhesion of symbiont to host cell (GO:0044650) | 2.94932514 |
| 45 | response to peptidoglycan (GO:0032494) | 2.91916263 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 2.90248137 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 2.90248137 |
| 48 | macromolecular complex remodeling (GO:0034367) | 2.90248137 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 2.89448881 |
| 50 | complement activation (GO:0006956) | 2.89147522 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.88047308 |
| 52 | regulation of apoptotic cell clearance (GO:2000425) | 2.86335447 |
| 53 | detection of other organism (GO:0098543) | 2.84313198 |
| 54 | regulation of fibrinolysis (GO:0051917) | 2.83906727 |
| 55 | protein-lipid complex assembly (GO:0065005) | 2.83390079 |
| 56 | complement activation, classical pathway (GO:0006958) | 2.83209655 |
| 57 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.82953120 |
| 58 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.82908581 |
| 59 | aromatic amino acid family catabolic process (GO:0009074) | 2.81448970 |
| 60 | phospholipid homeostasis (GO:0055091) | 2.81357625 |
| 61 | regulation of extracellular matrix disassembly (GO:0010715) | 2.80665248 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 2.77906530 |
| 63 | 4-hydroxyproline metabolic process (GO:0019471) | 2.77171601 |
| 64 | barbed-end actin filament capping (GO:0051016) | 2.76802777 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 2.76345372 |
| 66 | lipoprotein metabolic process (GO:0042157) | 2.75785494 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.75239373 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 2.73055783 |
| 69 | cholesterol efflux (GO:0033344) | 2.72788634 |
| 70 | detection of bacterium (GO:0016045) | 2.71480173 |
| 71 | detection of external biotic stimulus (GO:0098581) | 2.71437323 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 2.70966563 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.69497683 |
| 74 | cellular extravasation (GO:0045123) | 2.69448890 |
| 75 | negative regulation of sterol transport (GO:0032372) | 2.67025957 |
| 76 | negative regulation of cholesterol transport (GO:0032375) | 2.67025957 |
| 77 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.66497207 |
| 78 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.65170429 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 2.64560752 |
| 80 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.64428185 |
| 81 | cysteine metabolic process (GO:0006534) | 2.63332419 |
| 82 | adhesion of symbiont to host (GO:0044406) | 2.60947636 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 2.60467847 |
| 84 | bile acid biosynthetic process (GO:0006699) | 2.60391550 |
| 85 | glyoxylate metabolic process (GO:0046487) | 2.60236195 |
| 86 | positive regulation of coagulation (GO:0050820) | 2.59900903 |
| 87 | protein-lipid complex subunit organization (GO:0071825) | 2.59773875 |
| 88 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.59091560 |
| 89 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.58380116 |
| 90 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.57420451 |
| 91 | positive regulation of hemostasis (GO:1900048) | 2.57338015 |
| 92 | positive regulation of blood coagulation (GO:0030194) | 2.57338015 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 2.55700698 |
| 94 | positive regulation of interferon-alpha production (GO:0032727) | 2.55234912 |
| 95 | plasma lipoprotein particle organization (GO:0071827) | 2.55119764 |
| 96 | kynurenine metabolic process (GO:0070189) | 2.55080187 |
| 97 | cellular modified amino acid catabolic process (GO:0042219) | 2.54894707 |
| 98 | protein activation cascade (GO:0072376) | 2.54176386 |
| 99 | response to muramyl dipeptide (GO:0032495) | 2.54070407 |
| 100 | positive regulation of histone deacetylation (GO:0031065) | 2.53961480 |
| 101 | regulation of gamma-delta T cell activation (GO:0046643) | 2.53697729 |
| 102 | homocysteine metabolic process (GO:0050667) | 2.52428830 |
| 103 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.51835588 |
| 104 | detection of molecule of bacterial origin (GO:0032490) | 2.51459258 |
| 105 | opsonization (GO:0008228) | 2.51007623 |
| 106 | protein localization to endosome (GO:0036010) | 2.50884158 |
| 107 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.50538407 |
| 108 | neutrophil activation involved in immune response (GO:0002283) | 2.48825277 |
| 109 | lysine metabolic process (GO:0006553) | 2.47900602 |
| 110 | lysine catabolic process (GO:0006554) | 2.47900602 |
| 111 | response to type I interferon (GO:0034340) | 2.46277928 |
| 112 | negative regulation of granulocyte differentiation (GO:0030853) | 2.46172467 |
| 113 | pentose-phosphate shunt (GO:0006098) | 2.46124341 |
| 114 | protein retention in ER lumen (GO:0006621) | 2.46042365 |
| 115 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.45885261 |
| 116 | regulation of leukocyte degranulation (GO:0043300) | 2.43231831 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.43132780 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.43132780 |
| 119 | skin morphogenesis (GO:0043589) | 2.41927032 |
| 120 | regulation of interferon-alpha production (GO:0032647) | 2.41219065 |
| 121 | * mannose metabolic process (GO:0006013) | 2.40833410 |
| 122 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.40411560 |
| 123 | tricarboxylic acid metabolic process (GO:0072350) | 2.39473145 |
| 124 | leukocyte aggregation (GO:0070486) | 2.35960167 |
| 125 | negative regulation of interleukin-6 production (GO:0032715) | 2.34550504 |
| 126 | positive thymic T cell selection (GO:0045059) | 2.34472131 |
| 127 | negative regulation of type 2 immune response (GO:0002829) | 2.34448402 |
| 128 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.33012684 |
| 129 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.32943098 |
| 130 | response to laminar fluid shear stress (GO:0034616) | 2.32807918 |
| 131 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.31259887 |
| 132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.30545234 |
| 133 | detection of biotic stimulus (GO:0009595) | 2.30248598 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.29149508 |
| 135 | stress fiber assembly (GO:0043149) | 2.29091082 |
| 136 | regulation of T cell tolerance induction (GO:0002664) | 2.27958107 |
| 137 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.27805570 |
| 138 | positive regulation of extracellular matrix organization (GO:1903055) | 2.25723040 |
| 139 | germinal center formation (GO:0002467) | 2.25443298 |
| 140 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.23465152 |
| 141 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.20461361 |
| 142 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.19177959 |
| 143 | regulation of macrophage cytokine production (GO:0010935) | 2.18219708 |
| 144 | immunoglobulin mediated immune response (GO:0016064) | 2.18023496 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.17035063 |
| 146 | negative thymic T cell selection (GO:0045060) | 2.15664101 |
| 147 | positive regulation of receptor recycling (GO:0001921) | 2.14383234 |
| 148 | regulation of tolerance induction (GO:0002643) | 2.13988251 |
| 149 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.12537481 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.11724245 |
| 151 | response to host (GO:0075136) | 2.11585834 |
| 152 | response to host defenses (GO:0052200) | 2.11585834 |
| 153 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.11585834 |
| 154 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.11339045 |
| 155 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.10759589 |
| 156 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.10204340 |
| 157 | macrophage activation (GO:0042116) | 2.09514063 |
| 158 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.09073284 |
| 159 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.08696625 |
| 160 | endodermal cell differentiation (GO:0035987) | 2.08578500 |
| 161 | regulation of regulated secretory pathway (GO:1903305) | 2.08000173 |
| 162 | negative T cell selection (GO:0043383) | 2.07729040 |
| 163 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.07178053 |
| 164 | response to host immune response (GO:0052572) | 2.06557517 |
| 165 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.06557517 |
| 166 | type B pancreatic cell proliferation (GO:0044342) | 2.06488584 |
| 167 | thymic T cell selection (GO:0045061) | 2.06199981 |
| 168 | tolerance induction (GO:0002507) | 2.05949289 |
| 169 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.05734052 |
| 170 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.04583983 |
| 171 | regulation of type 2 immune response (GO:0002828) | 2.04224088 |
| 172 | NIK/NF-kappaB signaling (GO:0038061) | 2.03321547 |
| 173 | negative regulation of fatty acid transport (GO:2000192) | 2.02980677 |
| 174 | T cell selection (GO:0045058) | 2.02510030 |
| 175 | negative regulation of T cell mediated immunity (GO:0002710) | 2.02162436 |
| 176 | protein heterotrimerization (GO:0070208) | 2.01977565 |
| 177 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.01699736 |
| 178 | negative regulation of innate immune response (GO:0045824) | 2.00896450 |
| 179 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.98777593 |
| 180 | myeloid dendritic cell differentiation (GO:0043011) | 1.97883639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.55685132 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.10449238 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.80529619 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.61802179 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.37036637 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.07025493 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.55668046 |
| 8 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51297799 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40945635 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.38707505 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37115058 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37069866 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32728226 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27395085 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.22900763 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04457749 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03833430 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03534741 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01231057 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01190198 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99529921 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98655554 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.97183437 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96990506 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.95023073 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.91536451 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89491851 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85046660 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83532991 |
| 30 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.78534090 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.76248899 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74228750 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73227359 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72469570 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70809329 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68457309 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.65807753 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65434694 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63962816 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63082511 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61902177 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61699746 |
| 43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59174763 |
| 44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55989150 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54818442 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53429642 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53086775 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.44454936 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39012515 |
| 50 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.38161087 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36808225 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.36455439 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35620082 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33157801 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31311969 |
| 56 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30855420 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29536414 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29316943 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27851841 |
| 60 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27081170 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26769046 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26634873 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25344432 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24613658 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.19352033 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18406843 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18137403 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17967742 |
| 69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17311213 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16909743 |
| 71 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16770966 |
| 72 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.16625527 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16506890 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15739114 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15112466 |
| 76 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14741584 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14157544 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13553565 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12578078 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11979963 |
| 81 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10329359 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10100705 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09680579 |
| 84 | MYB_26560356_Chip-Seq_TH1_Human | 1.09510066 |
| 85 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08117457 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07537551 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07533885 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07053799 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06268565 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04417536 |
| 91 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.04171016 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 1.04161850 |
| 93 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04037518 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03089952 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02539390 |
| 96 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.02283165 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02282137 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02152354 |
| 99 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02072758 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01482377 |
| 101 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00960443 |
| 102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00584172 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00525389 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00466956 |
| 105 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00320518 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00088909 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99244590 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98916760 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98708555 |
| 110 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97681735 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96397829 |
| 112 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96064062 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95153654 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95093532 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94875826 |
| 116 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94799720 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94799720 |
| 118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94658457 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94565108 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93955510 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92798318 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92735349 |
| 123 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92099279 |
| 124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91697935 |
| 125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89741934 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87215933 |
| 127 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86709348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 3.72667131 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.43075727 |
| 3 | MP0005360_urolithiasis | 3.38621069 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.30906684 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.20408216 |
| 6 | MP0005365_abnormal_bile_salt | 2.90691228 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.76224604 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.73684585 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.41955863 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.39245879 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.33804296 |
| 12 | MP0003252_abnormal_bile_duct | 2.25793768 |
| 13 | MP0003303_peritoneal_inflammation | 2.25435919 |
| 14 | MP0003436_decreased_susceptibility_to | 2.18324280 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06840068 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.02329134 |
| 17 | MP0001835_abnormal_antigen_presentation | 1.78941866 |
| 18 | MP0006082_CNS_inflammation | 1.78101987 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.74887735 |
| 20 | MP0005083_abnormal_biliary_tract | 1.69360368 |
| 21 | MP0002419_abnormal_innate_immunity | 1.65450998 |
| 22 | MP0003279_aneurysm | 1.63926022 |
| 23 | MP0001542_abnormal_bone_strength | 1.59659732 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.58060386 |
| 25 | MP0000604_amyloidosis | 1.57896880 |
| 26 | MP0000609_abnormal_liver_physiology | 1.57893749 |
| 27 | MP0000685_abnormal_immune_system | 1.56615010 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.56575652 |
| 29 | MP0005670_abnormal_white_adipose | 1.56286779 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.54920200 |
| 31 | MP0006054_spinal_hemorrhage | 1.48732782 |
| 32 | MP0005164_abnormal_response_to | 1.43811290 |
| 33 | MP0005387_immune_system_phenotype | 1.43747115 |
| 34 | MP0001790_abnormal_immune_system | 1.43747115 |
| 35 | MP0004883_abnormal_blood_vessel | 1.42057267 |
| 36 | MP0005275_abnormal_skin_tensile | 1.39211201 |
| 37 | MP0000858_altered_metastatic_potential | 1.36543891 |
| 38 | MP0003828_pulmonary_edema | 1.31184955 |
| 39 | MP0003195_calcinosis | 1.29423051 |
| 40 | MP0008469_abnormal_protein_level | 1.29296355 |
| 41 | MP0005332_abnormal_amino_acid | 1.29127255 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.29044981 |
| 43 | MP0005025_abnormal_response_to | 1.28906098 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.28534874 |
| 45 | MP0004947_skin_inflammation | 1.28343202 |
| 46 | MP0003329_amyloid_beta_deposits | 1.28098760 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.27699198 |
| 48 | MP0001958_emphysema | 1.27015608 |
| 49 | MP0003724_increased_susceptibility_to | 1.26212823 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.24170377 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.23737823 |
| 52 | MP0005023_abnormal_wound_healing | 1.23308400 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.21908402 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.21135024 |
| 55 | MP0002254_reproductive_system_inflammat | 1.20275080 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.18781882 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.18774672 |
| 58 | MP0003075_altered_response_to | 1.18494334 |
| 59 | MP0008260_abnormal_autophagy | 1.17856660 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.16901668 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.16855654 |
| 62 | MP0001800_abnormal_humoral_immune | 1.13950888 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.12485972 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.11616720 |
| 65 | MP0009278_abnormal_bone_marrow | 1.11071103 |
| 66 | MP0004272_abnormal_basement_membrane | 1.08769677 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.08271485 |
| 68 | MP0005451_abnormal_body_composition | 1.06722874 |
| 69 | MP0000598_abnormal_liver_morphology | 1.05757055 |
| 70 | MP0000343_altered_response_to | 1.04767214 |
| 71 | MP0002933_joint_inflammation | 1.04560107 |
| 72 | MP0009785_altered_susceptibility_to | 1.04098708 |
| 73 | MP0002723_abnormal_immune_serum | 1.03733143 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.03097585 |
| 75 | MP0001851_eye_inflammation | 1.03051280 |
| 76 | MP0001348_abnormal_lacrimal_gland | 1.01716271 |
| 77 | MP0001853_heart_inflammation | 0.98536990 |
| 78 | MP0005310_abnormal_salivary_gland | 0.98081921 |
| 79 | MP0002928_abnormal_bile_duct | 0.97007511 |
| 80 | MP0000249_abnormal_blood_vessel | 0.94806011 |
| 81 | MP0009764_decreased_sensitivity_to | 0.93782225 |
| 82 | MP0000716_abnormal_immune_system | 0.93279617 |
| 83 | MP0004510_myositis | 0.93257448 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92828520 |
| 85 | MP0002405_respiratory_system_inflammati | 0.92694974 |
| 86 | MP0003795_abnormal_bone_structure | 0.92443363 |
| 87 | MP0005595_abnormal_vascular_smooth | 0.92237174 |
| 88 | MP0003045_fibrosis | 0.92177742 |
| 89 | MP0003690_abnormal_glial_cell | 0.91617005 |
| 90 | MP0001819_abnormal_immune_cell | 0.91537712 |
| 91 | MP0004130_abnormal_muscle_cell | 0.91419626 |
| 92 | MP0002420_abnormal_adaptive_immunity | 0.91063038 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 0.89893708 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 0.89835301 |
| 95 | MP0009763_increased_sensitivity_to | 0.89687608 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.89027864 |
| 97 | MP0004858_abnormal_nervous_system | 0.88361949 |
| 98 | MP0005671_abnormal_response_to | 0.88145033 |
| 99 | MP0005166_decreased_susceptibility_to | 0.88012067 |
| 100 | MP0005390_skeleton_phenotype | 0.86797982 |
| 101 | MP0010307_abnormal_tumor_latency | 0.86741315 |
| 102 | MP0008004_abnormal_stomach_pH | 0.86511968 |
| 103 | MP0001849_ear_inflammation | 0.86417802 |
| 104 | MP0005503_abnormal_tendon_morphology | 0.86107796 |
| 105 | MP0003866_abnormal_defecation | 0.85026367 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.84307406 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.83607194 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.83105277 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.82987755 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.82707435 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.82700667 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.82655465 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 0.82439586 |
| 114 | MP0001915_intracranial_hemorrhage | 0.80132125 |
| 115 | MP0002168_other_aberrant_phenotype | 0.79660750 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.79611378 |
| 117 | MP0010155_abnormal_intestine_physiology | 0.78125643 |
| 118 | MP0003091_abnormal_cell_migration | 0.77817015 |
| 119 | MP0002060_abnormal_skin_morphology | 0.77779188 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.77730571 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.76980283 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.76548151 |
| 123 | MP0003448_altered_tumor_morphology | 0.75840747 |
| 124 | MP0001756_abnormal_urination | 0.75632805 |
| 125 | MP0010368_abnormal_lymphatic_system | 0.73936634 |
| 126 | MP0000920_abnormal_myelination | 0.73289972 |
| 127 | MP0001873_stomach_inflammation | 0.72306076 |
| 128 | MP0002398_abnormal_bone_marrow | 0.71071266 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.70545214 |
| 130 | MP0001663_abnormal_digestive_system | 0.70388360 |
| 131 | MP0008874_decreased_physiological_sensi | 0.68538085 |
| 132 | MP0003879_abnormal_hair_cell | 0.67747783 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.66896027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.65217822 |
| 2 | Dysostosis multiplex (HP:0000943) | 4.33466733 |
| 3 | Mucopolysacchariduria (HP:0008155) | 4.14786394 |
| 4 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.14786394 |
| 5 | Complement deficiency (HP:0004431) | 4.10882430 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.91117721 |
| 7 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.89790746 |
| 8 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.89790746 |
| 9 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.89790746 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.80124606 |
| 11 | Glomerulonephritis (HP:0000099) | 3.60754432 |
| 12 | Xanthomatosis (HP:0000991) | 3.57312729 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.50496868 |
| 14 | Abnormality of complement system (HP:0005339) | 3.43068481 |
| 15 | Cerebral aneurysm (HP:0004944) | 3.24629284 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.23275711 |
| 17 | Protrusio acetabuli (HP:0003179) | 3.14648967 |
| 18 | Myocardial infarction (HP:0001658) | 3.12250997 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11152614 |
| 20 | Myositis (HP:0100614) | 3.08155432 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.95157260 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 2.95157260 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.95157260 |
| 24 | Peritonitis (HP:0002586) | 2.91347459 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.88098903 |
| 26 | Cervical subluxation (HP:0003308) | 2.84111136 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.84005073 |
| 28 | Orchitis (HP:0100796) | 2.81236120 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.80862866 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76992888 |
| 31 | Joint hemorrhage (HP:0005261) | 2.76883340 |
| 32 | Mitral stenosis (HP:0001718) | 2.73611182 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 2.72865140 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69252053 |
| 35 | Nephritis (HP:0000123) | 2.66155743 |
| 36 | Hyperlipoproteinemia (HP:0010980) | 2.63151125 |
| 37 | Premature rupture of membranes (HP:0001788) | 2.63110004 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.59168137 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 2.56834089 |
| 40 | Loss of speech (HP:0002371) | 2.54023030 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.52769942 |
| 42 | Nasal polyposis (HP:0100582) | 2.50609111 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 2.41869387 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.40055032 |
| 45 | Spondylolisthesis (HP:0003302) | 2.37911534 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.37554047 |
| 47 | Axonal loss (HP:0003447) | 2.37507798 |
| 48 | Atrophic scars (HP:0001075) | 2.34524343 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.34509665 |
| 50 | Optic neuritis (HP:0100653) | 2.34220191 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.34220191 |
| 52 | Aortic aneurysm (HP:0004942) | 2.28526279 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.25331527 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.23994353 |
| 55 | Vertebral compression fractures (HP:0002953) | 2.23639649 |
| 56 | Aortic dissection (HP:0002647) | 2.22918046 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.21654981 |
| 58 | Hand muscle atrophy (HP:0009130) | 2.21221455 |
| 59 | Thoracic kyphosis (HP:0002942) | 2.20583753 |
| 60 | Blue sclerae (HP:0000592) | 2.19977722 |
| 61 | Emphysema (HP:0002097) | 2.19472581 |
| 62 | Genu recurvatum (HP:0002816) | 2.18765219 |
| 63 | Ovoid vertebral bodies (HP:0003300) | 2.18391932 |
| 64 | Ankle contracture (HP:0006466) | 2.18119693 |
| 65 | Gingival bleeding (HP:0000225) | 2.17390653 |
| 66 | Gingivitis (HP:0000230) | 2.17032887 |
| 67 | Obstructive sleep apnea (HP:0002870) | 2.16491997 |
| 68 | Skin nodule (HP:0200036) | 2.15154733 |
| 69 | Amyloidosis (HP:0011034) | 2.13207310 |
| 70 | Retinal atrophy (HP:0001105) | 2.13055179 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.12969160 |
| 72 | Joint stiffness (HP:0001387) | 2.12821049 |
| 73 | Abnormality of macrophages (HP:0004311) | 2.10437005 |
| 74 | Thin bony cortex (HP:0002753) | 2.10046189 |
| 75 | Hematochezia (HP:0002573) | 2.08848152 |
| 76 | Stomatitis (HP:0010280) | 2.07254224 |
| 77 | Ketosis (HP:0001946) | 2.06945868 |
| 78 | Neurofibrillary tangles (HP:0002185) | 2.06939501 |
| 79 | Fragile skin (HP:0001030) | 2.06870184 |
| 80 | J-shaped sella turcica (HP:0002680) | 2.04952510 |
| 81 | Recurrent fungal infections (HP:0002841) | 2.04650995 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 2.02105435 |
| 83 | Upper limb amyotrophy (HP:0009129) | 2.02105435 |
| 84 | Recurrent skin infections (HP:0001581) | 2.01604397 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.01541336 |
| 86 | Wormian bones (HP:0002645) | 2.01221632 |
| 87 | Menorrhagia (HP:0000132) | 1.99414487 |
| 88 | Pustule (HP:0200039) | 1.98839631 |
| 89 | Bladder diverticulum (HP:0000015) | 1.98816920 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 1.98080844 |
| 91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97283469 |
| 92 | Pulmonary infiltrates (HP:0002113) | 1.96776833 |
| 93 | Aneurysm (HP:0002617) | 1.96374953 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96301134 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96301134 |
| 96 | Mitral valve prolapse (HP:0001634) | 1.95279301 |
| 97 | Late onset (HP:0003584) | 1.95223100 |
| 98 | Abnormal platelet function (HP:0011869) | 1.94747956 |
| 99 | Impaired platelet aggregation (HP:0003540) | 1.94747956 |
| 100 | Epidermoid cyst (HP:0200040) | 1.94242199 |
| 101 | Esophageal varix (HP:0002040) | 1.93916870 |
| 102 | Hypolipoproteinemia (HP:0010981) | 1.93911575 |
| 103 | Follicular hyperkeratosis (HP:0007502) | 1.93512228 |
| 104 | Abnormality of the lumbar spine (HP:0100712) | 1.93144856 |
| 105 | Osteolytic defects of the hand bones (HP:0009699) | 1.91761924 |
| 106 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91761924 |
| 107 | Broad face (HP:0000283) | 1.91626361 |
| 108 | Disproportionate tall stature (HP:0001519) | 1.90401812 |
| 109 | Hemoptysis (HP:0002105) | 1.89879219 |
| 110 | Purpura (HP:0000979) | 1.88853487 |
| 111 | Hemorrhage of the eye (HP:0011885) | 1.87315598 |
| 112 | Beaking of vertebral bodies (HP:0004568) | 1.87009477 |
| 113 | Abnormality of the thoracic spine (HP:0100711) | 1.86287053 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.86017593 |
| 115 | Arterial tortuosity (HP:0005116) | 1.85950126 |
| 116 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85677248 |
| 117 | Soft skin (HP:0000977) | 1.85645911 |
| 118 | Hypobetalipoproteinemia (HP:0003563) | 1.85537755 |
| 119 | Mediastinal lymphadenopathy (HP:0100721) | 1.85428286 |
| 120 | Pathologic fracture (HP:0002756) | 1.84973540 |
| 121 | Broad metatarsal (HP:0001783) | 1.84636797 |
| 122 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.84056676 |
| 123 | Increased IgE level (HP:0003212) | 1.83724040 |
| 124 | Cellulitis (HP:0100658) | 1.83609077 |
| 125 | Protuberant abdomen (HP:0001538) | 1.83402779 |
| 126 | Increased CSF protein (HP:0002922) | 1.83067171 |
| 127 | Slender build (HP:0001533) | 1.82927602 |
| 128 | Vascular tortuosity (HP:0004948) | 1.82028005 |
| 129 | Dilatation of the ascending aorta (HP:0005111) | 1.81295336 |
| 130 | Shallow orbits (HP:0000586) | 1.80761459 |
| 131 | Global brain atrophy (HP:0002283) | 1.80283897 |
| 132 | Spontaneous hematomas (HP:0007420) | 1.80254121 |
| 133 | Tetraparesis (HP:0002273) | 1.80085210 |
| 134 | Mitral regurgitation (HP:0001653) | 1.79695724 |
| 135 | Vasculitis (HP:0002633) | 1.78974957 |
| 136 | Aortic regurgitation (HP:0001659) | 1.78842337 |
| 137 | Colitis (HP:0002583) | 1.78738190 |
| 138 | Polycythemia (HP:0001901) | 1.78587503 |
| 139 | Periodontitis (HP:0000704) | 1.77750357 |
| 140 | Striae distensae (HP:0001065) | 1.77739330 |
| 141 | Increased connective tissue (HP:0009025) | 1.74155627 |
| 142 | Spinal rigidity (HP:0003306) | 1.72139383 |
| 143 | Epistaxis (HP:0000421) | 1.70309567 |
| 144 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70051765 |
| 145 | Flared iliac wings (HP:0002869) | 1.68951177 |
| 146 | Cerebral inclusion bodies (HP:0100314) | 1.68534754 |
| 147 | Joint laxity (HP:0001388) | 1.68092097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.87504411 |
| 2 | TRIB3 | 4.10079858 |
| 3 | PKN2 | 2.97582648 |
| 4 | MAP4K1 | 2.63967768 |
| 5 | SIK1 | 2.63480942 |
| 6 | TGFBR2 | 2.60386003 |
| 7 | PRPF4B | 2.39927186 |
| 8 | TAOK3 | 2.21323510 |
| 9 | TYK2 | 2.16906416 |
| 10 | FGFR4 | 1.96420251 |
| 11 | TBK1 | 1.87807499 |
| 12 | RIPK1 | 1.86323535 |
| 13 | EPHB1 | 1.84832992 |
| 14 | PTK6 | 1.83544806 |
| 15 | EEF2K | 1.81822240 |
| 16 | JAK3 | 1.70210652 |
| 17 | ZAP70 | 1.62535883 |
| 18 | PRKD2 | 1.62292045 |
| 19 | JAK1 | 1.61404269 |
| 20 | CAMK1D | 1.60430702 |
| 21 | CSF1R | 1.60034401 |
| 22 | FLT3 | 1.58371903 |
| 23 | TTN | 1.56969937 |
| 24 | CDC42BPA | 1.55845454 |
| 25 | MAP3K10 | 1.55448614 |
| 26 | KIT | 1.54725621 |
| 27 | BCKDK | 1.53087444 |
| 28 | MST1R | 1.42820958 |
| 29 | TAOK1 | 1.38039929 |
| 30 | MAP3K13 | 1.36297163 |
| 31 | SCYL2 | 1.34859910 |
| 32 | MAP2K3 | 1.33293248 |
| 33 | LRRK2 | 1.32095975 |
| 34 | BLK | 1.32075353 |
| 35 | CAMK1G | 1.29478401 |
| 36 | MARK2 | 1.28857275 |
| 37 | PDGFRA | 1.25297892 |
| 38 | IRAK3 | 1.24486106 |
| 39 | PAK4 | 1.22700527 |
| 40 | MYLK | 1.20715152 |
| 41 | TNK2 | 1.20367797 |
| 42 | BTK | 1.19330906 |
| 43 | CSK | 1.19089886 |
| 44 | INSRR | 1.16162630 |
| 45 | MAPK15 | 1.13620869 |
| 46 | TAOK2 | 1.13246450 |
| 47 | STK10 | 1.13008780 |
| 48 | BMX | 1.10838550 |
| 49 | TESK1 | 1.10185851 |
| 50 | GRK7 | 1.10173039 |
| 51 | JAK2 | 1.08751401 |
| 52 | MAPK7 | 1.04585620 |
| 53 | STK38 | 1.01981370 |
| 54 | HCK | 1.00935280 |
| 55 | GRK6 | 0.93906686 |
| 56 | PTK2 | 0.93070762 |
| 57 | KDR | 0.90087832 |
| 58 | ICK | 0.89356027 |
| 59 | NEK9 | 0.85494309 |
| 60 | EPHA3 | 0.85124285 |
| 61 | IRAK4 | 0.83847176 |
| 62 | DYRK1B | 0.83732770 |
| 63 | MAP3K6 | 0.81185492 |
| 64 | TXK | 0.80840635 |
| 65 | MAPK12 | 0.80111575 |
| 66 | MAP3K3 | 0.79489160 |
| 67 | ITK | 0.79020015 |
| 68 | SYK | 0.76725871 |
| 69 | IKBKE | 0.76141426 |
| 70 | IRAK2 | 0.74703267 |
| 71 | MOS | 0.74685172 |
| 72 | PIK3CG | 0.73730912 |
| 73 | TESK2 | 0.73250820 |
| 74 | SMG1 | 0.72402743 |
| 75 | FGFR3 | 0.71292890 |
| 76 | PAK2 | 0.71222337 |
| 77 | IKBKB | 0.70488965 |
| 78 | EPHB2 | 0.67443255 |
| 79 | MET | 0.66816076 |
| 80 | RPS6KC1 | 0.66733778 |
| 81 | RPS6KL1 | 0.66733778 |
| 82 | MAP3K14 | 0.66229035 |
| 83 | CDK6 | 0.65503092 |
| 84 | MTOR | 0.65206635 |
| 85 | LCK | 0.64380027 |
| 86 | FES | 0.63891489 |
| 87 | DDR2 | 0.63084182 |
| 88 | FGR | 0.62425659 |
| 89 | CAMKK1 | 0.62013487 |
| 90 | RPS6KA6 | 0.60967420 |
| 91 | PRKCH | 0.60467162 |
| 92 | RPS6KA4 | 0.60052488 |
| 93 | MAP3K1 | 0.59688030 |
| 94 | CHUK | 0.59244609 |
| 95 | CDK12 | 0.56916869 |
| 96 | MAPK11 | 0.55967963 |
| 97 | PDPK1 | 0.55926307 |
| 98 | KSR2 | 0.55732310 |
| 99 | PDK1 | 0.55191379 |
| 100 | LYN | 0.54085741 |
| 101 | RIPK4 | 0.53077008 |
| 102 | HIPK2 | 0.52514802 |
| 103 | RET | 0.51980913 |
| 104 | SIK2 | 0.51818169 |
| 105 | MARK3 | 0.51404608 |
| 106 | MAP3K11 | 0.50841135 |
| 107 | MATK | 0.50612894 |
| 108 | RPS6KA2 | 0.49945765 |
| 109 | EGFR | 0.49463126 |
| 110 | SGK3 | 0.49273112 |
| 111 | PDK3 | 0.48396639 |
| 112 | PDK4 | 0.48396639 |
| 113 | PTK2B | 0.47542973 |
| 114 | PDGFRB | 0.47428343 |
| 115 | PIM2 | 0.47334163 |
| 116 | PRKD1 | 0.47277548 |
| 117 | IRAK1 | 0.46861155 |
| 118 | MAP2K6 | 0.46859000 |
| 119 | PIM1 | 0.46824038 |
| 120 | SIK3 | 0.46737576 |
| 121 | NTRK1 | 0.46405507 |
| 122 | FYN | 0.45903735 |
| 123 | GRK5 | 0.45856079 |
| 124 | DAPK2 | 0.45806333 |
| 125 | IGF1R | 0.45796899 |
| 126 | TRPM7 | 0.43325441 |
| 127 | CAMKK2 | 0.41788941 |
| 128 | MAP3K7 | 0.41010612 |
| 129 | PRKD3 | 0.40978496 |
| 130 | TEC | 0.40765070 |
| 131 | MAPK4 | 0.40377002 |
| 132 | ABL1 | 0.39032867 |
| 133 | PRKG2 | 0.38449960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.28824138 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.16272783 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77927464 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.68618604 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.66687860 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35196608 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.25449478 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03546247 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01330691 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.00171930 |
| 11 | * Other glycan degradation_Homo sapiens_hsa00511 | 1.85509466 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84918175 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79724220 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.72033408 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70376844 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63424438 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53438847 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42031391 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38108251 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37335466 |
| 21 | ABC transporters_Homo sapiens_hsa02010 | 1.35054574 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33067283 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32048948 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.31644173 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28347881 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28156966 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27673402 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26762462 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24244112 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22610317 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.21646633 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19421661 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15265188 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14734745 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.11595788 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05341925 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04525321 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04394230 |
| 39 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04127618 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.03872309 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02785304 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02726325 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 1.02442028 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99161521 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98606826 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 0.98151659 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.98096100 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97638858 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97625106 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97520683 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97269454 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95090845 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94228355 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93786639 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.93307688 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92972539 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91973068 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91847102 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90910240 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90361386 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89783032 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89575568 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89041846 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85824904 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84197011 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84023120 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83836613 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82287542 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82274265 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.81976017 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.81870369 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.81709658 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81594200 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81060043 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.80571996 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80540034 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.80226192 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80099293 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79532299 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79431101 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79114067 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78207452 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.77820264 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.76779484 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76207707 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.76170703 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75307087 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.72999810 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72527477 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72364367 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71780264 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71724494 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71346074 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71155558 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70664437 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69265847 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68257058 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67845041 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67838135 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66964827 |
| 101 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66760152 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66396417 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66330486 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65924610 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65530858 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65319235 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65182474 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64321695 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64309799 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64039486 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63766504 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63150974 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.62445194 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61155354 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60385134 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.58894113 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58027700 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57659482 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56274882 |
| 120 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56024940 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55721422 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.54494499 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52754509 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52268090 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51825165 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51239035 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50680483 |
| 128 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50442109 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49766058 |
| 130 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48906351 |
| 131 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48064935 |
| 132 | Apoptosis_Homo sapiens_hsa04210 | 0.47879453 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47725632 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.47657843 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47394805 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47157865 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46932879 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46660945 |
| 139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46495411 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45730774 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43839674 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43654777 |
| 143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43588914 |
| 144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43291770 |
| 145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43118889 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.41694951 |
| 147 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41521626 |
| 148 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40407068 |
| 149 | Influenza A_Homo sapiens_hsa05164 | 0.39285992 |
| 150 | Shigellosis_Homo sapiens_hsa05131 | 0.38630660 |
| 151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38580675 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38495878 |
| 153 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38469750 |
| 154 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37711189 |
| 155 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37505344 |

